1.
Curr Opin Investig Drugs
; 6(4): 435-44, 2005 Apr.
Article
in English
| MEDLINE
| ID: mdl-15898351
ABSTRACT
Strontium ranelate (PROTELOS), a divalent strontium salt, has been developed and launched by Servier for the treatment of osteoporosis. Fujisawa Pharmaceutical is developing the drug in Japan; in November 2004, phase II Japanese trials were ongoing.